Association between sorbitol dehydrogenase gene polymorphisms and type 2 diabetic retinopathy

Experimental Eye Research

Volumn 86, Issue 4, 2008, Pages 647-652

  Szaflik, Jacek P ^a   Majsterek, Ireneusz ^b   Kowalski, Michal ^a   Rusin, Pawel ^b   Sobczuk, Anna ^c   Borucka, Anna I ^a   Szaflik, Jerzy ^a   Blasiak, Janusz ^b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b UNIVERSITY OF LODZ   (Poland)

^c POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

diabetic retinopathy; genetic polymorphism; restriction fragment length polymorphism; sorbitol dehydrogenase

Indexed keywords

IDITOL DEHYDROGENASE;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL LYMPHOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; L-IDITOL 2-DEHYDROGENASE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS (GENETICS);

EID: 41049097649     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2008.01.009     Document Type: Article

References (25)

1. Amano S., Yamagishi S., Kato N., Inagaki Y., Okamoto T., Makino M., Taniko K., Hirooka H., Jomori T., and Takeuchi M. Sorbitol dehydrogenase overexpression potentiates glucose toxicity to cultured pericytes. Biochem. Biophys. Res. Commun. 299 (2002) 183-188
2. Amano S., Yamagishi S., Koda Y., Tsuneoka M., Soejima M., Okamoto T., Inagaki Y., Yamada K., and Kimura H. Polymorphisms of sorbitol dehydrogenase (SDH) gene and susceptibility to diabetic retinopathy. Med. Hypotheses 60 (2003) 550-551
3. Awata T., Inoue K., Kurihara S., Ohkubo T., Watanabe M., Inukai K., Inoue I., and Katayama S. A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 51 (2002) 1635-1639
4. Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy. Early Treatment Diabetic Retinopathy Study Report 12. Ophthalmology 98 (1991) 823-833
5. Funk M., Endler G., Exner M., Marculescu R., Endler L., Abrahamian H., Mauler H., Grimm A., Raith M., Mannhalter C., Praqer R., Irsiqler K., and Wagner O.F. PAI-1 4G/5G insertion/deletion promoter polymorphism and microvascular complications in type 2 diabetes mellitus. Wien. Klin. Wochenschr. 117 (2005) 707-710
6. Hellgren M., Kaiser C., de Haij D., Norberg A., and Hoog J.O. A hydrogen-bonding network in mammalian sorbitol dehydrogenase stabilizes the tetrameric state and is essential for the catalytic power. Cell. Mol. Life Sci. 64 (2007) 3129-3138
7. Iwata T., Popescu N.C., Zimonjic D.B., Karlsson C., Hoog J.-O., Vaca G., Rodriguez I.R., and Carper D. Structural organization of the human sorbitol dehydrogenase gene (SORD). Genomics 26 (1995) 55-62
8. Kao Y.-L., Donaghue K., Chan A., Knight J., and Silink M. An aldose reductase intragenic polymorphism associated with diabetic retinopathy. Diabetes Res. Clin. Pract. 46 (1999) 155-160
9. King H., Aubert R.E., and Herman W.H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21 (1998) 1414-1431
10. Kinoshita J.H., and Nishimura C. The involvement of aldose reductase in diabetic complications. Diabetes Metab. Rev. 4 (1988) 323-337
11. Klein R., Klein B.E., Moss S.E., Davis M.D., and DeMets D.L. The Wisconsin study of epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch. Ophthalmol. 102 (1984) 527-532
12. Klein R., and Klein B.E.K. Vision disorders in diabetes. In: Harris M.I., Cowie C.C., Stern M.P., et al. (Eds). National Diabetes Data Group: Diabetes in America (1995), National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda 293-338 Publication No. 95-1468
13. Lee P., Wang C.C., and Adamis A. Ocular neovascularization: an epidemiological review. Surv. Ophthalmol. 43 (1998) 245-269
14. Liu L., Yu O., Wang H., Zhang S.X., Huang C., and Chen X. Association of intercellular adhesion molecule 1 polymorphisms with retinopathy in Chinese patients with type 2 diabetes. Diabetes Med. 23 (2006) 643-648
15. Nagi D.K., McCormack L.J., Mohamed-Ali V., Yudkin J.S., Knowler W.C., and Grant P.J. Diabetic retinopathy, promoter (4G/5G) polymorphism of PAI-1 gene, and PAI-1 activity in Pima Indians with type 2 diabetes. Diabetes Care 20 (1997) 1304-1309
16. 23 [Z-2] polymorphism of the aldose reductase gene and fast progression of retinopathy in Chilean type 2 diabetics. Diabetes Res. Clin. Pract. 47 (2000) 169-176
17. Olmos P., Bastias M.J., Vollrath V., Toro L., Trincado A., Salinas P., Claro J.C., Lopez J.M., Acosta A.M., Miguel J.F., and Castro J. C(-106)T polymorphism of the aldose reductase gene and the progression rate of diabetic retinopathy. Diabetes Res. Clin. Pract. 74 (2006) 75-82
18. n gene polymorphism and susceptibility to diabetic retinopathy in type 2 diabetes in Caucasians. J. Diabetes Complicat. 19 (2005) 70-73
19. Ramprasad S., Radha V., Mathias R.A., Majumder P.P., Rao M.R., and Rema M. RAGE gene promoter polymorphisms and diabetic retinopathy in a clinic-based population from South India. Eye 21 (2007) 395-401
20. Rietveld I., Ikram M.K., Vingerling J.R., Hofman A., Pols H.A., Lamberts S.W., de Jong P.T., van Duijn C.M., and Janssen J.A. An igf-1 gene polymorphism modifies the risk of diabetic retinopathy. Diabetes 55 (2006) 2387-2391
21. dos Santos K.G., Canani L.H., Gross J.L., Tschiedel B., Souto K.E., and Roisenberg I. The -106CC genotype of the aldose reductase gene is associated with an increased risk of proliferative diabetic retinopathy in Caucasian-Brazilians with type 2 diabetes. Mol. Genet. Metabol. 88 (2006) 280-284
22. Santos K.G., Tschiedel B., Schneider J., Souto K., and Roisenberg I. Diabetic retinopathy in Euro-Brazilian type 2 diabetic patients: relationship with polymorphisms in the aldose reductase, the plasminogen activator innhbitor-1 and the methylenetetrahydrofolate reductase genes. Diabetes Res. Clin. Pract. 61 (2003) 133-136
23. Suganthalakshmi B., Anand R., Kim R., Mahalakshmi R., Karthikprash S., Namperumalsamy P., and Sundaresan P. Association of VEGF and eNOS gene polymorphisms in type 2 diabetic retinopathy. Mol. Vis. 12 (2006) 336-341
24. Tilton R.G., Chang K., Nyengaard J.R., Van den Enden M., Ido Y., and Williamson J.R. Inhibition of sorbitol dehydrogenase. Effect on vascular and neural dysfunction in streptozocin-induced diabetic rats. Diabetes 44 (1995) 234-242
25. Vinik A. The protein kinase C-β inhibitor, ruboxistaurin, for the treatment of diabetic microvascular complications. Expert Opin. Investig. Drugs 14 (2005) 1547-1559